
Biologics analytical services refer to a range of specialized scientific and laboratory services provided to biopharmaceutical and biotechnology companies involved in the development, manufacturing, and quality control of biologic drugs and therapies. These services are essential for ensuring the safety, efficacy, and quality of biologic products.
The global Biologics Analytical Services market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The biopharmaceutical industry has been experiencing significant growth, with an increasing number of biologic drugs and therapies in development. This has led to a higher demand for analytical services to ensure the quality and safety of these products.
This report aims to provide a comprehensive presentation of the global market for Biologics Analytical Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologics Analytical Services.
Report Scope
The Biologics Analytical Services market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Biologics Analytical Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Biologics Analytical Services companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Âé¶¹Ô´´ Segmentation
By Company
Catalent
Almac
Lonza
Crystal Pharmatech
Frontage Labs
WuXi Biologics
ABS
Charles River
Sartorius
Avid Bioservices
Samsung Biologics
AGC Biologics
Biodextris
ChemPartner
LOTTE BIOLOGICS
Eurofins Advinus
Solvias
RSSL
Cytovance Biologics
Zencore Biologics
Segment by Type
Feasibility Analysis Services
Upstream And Downstream Support Services
Commercialization Services
Segment by Application
SMEs
Large Enterprises
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologics Analytical Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Biologics Analytical Services Âé¶¹Ô´´ Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Feasibility Analysis Services
1.2.3 Upstream And Downstream Support Services
1.2.4 Commercialization Services
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Biologics Analytical Services Âé¶¹Ô´´ Growth by Application: 2019 VS 2023 VS 2030
1.3.2 SMEs
1.3.3 Large Enterprises
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologics Analytical Services Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Biologics Analytical Services Growth Trends by Region
2.2.1 Global Biologics Analytical Services Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Biologics Analytical Services Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Biologics Analytical Services Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Biologics Analytical Services Âé¶¹Ô´´ Dynamics
2.3.1 Biologics Analytical Services Industry Trends
2.3.2 Biologics Analytical Services Âé¶¹Ô´´ Drivers
2.3.3 Biologics Analytical Services Âé¶¹Ô´´ Challenges
2.3.4 Biologics Analytical Services Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologics Analytical Services Players by Revenue
3.1.1 Global Top Biologics Analytical Services Players by Revenue (2019-2024)
3.1.2 Global Biologics Analytical Services Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Biologics Analytical Services Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologics Analytical Services Revenue
3.4 Global Biologics Analytical Services Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Biologics Analytical Services Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologics Analytical Services Revenue in 2023
3.5 Biologics Analytical Services Key Players Head office and Area Served
3.6 Key Players Biologics Analytical Services Product Solution and Service
3.7 Date of Enter into Biologics Analytical Services Âé¶¹Ô´´
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologics Analytical Services Breakdown Data by Type
4.1 Global Biologics Analytical Services Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Biologics Analytical Services Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Biologics Analytical Services Breakdown Data by Application
5.1 Global Biologics Analytical Services Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Biologics Analytical Services Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Biologics Analytical Services Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Biologics Analytical Services Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Biologics Analytical Services Âé¶¹Ô´´ Size by Country (2019-2024)
6.4 North America Biologics Analytical Services Âé¶¹Ô´´ Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologics Analytical Services Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Biologics Analytical Services Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Biologics Analytical Services Âé¶¹Ô´´ Size by Country (2019-2024)
7.4 Europe Biologics Analytical Services Âé¶¹Ô´´ Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologics Analytical Services Âé¶¹Ô´´ Size (2019-2030)
8.2 Asia-Pacific Biologics Analytical Services Âé¶¹Ô´´ Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Biologics Analytical Services Âé¶¹Ô´´ Size by Region (2019-2024)
8.4 Asia-Pacific Biologics Analytical Services Âé¶¹Ô´´ Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologics Analytical Services Âé¶¹Ô´´ Size (2019-2030)
9.2 Latin America Biologics Analytical Services Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Biologics Analytical Services Âé¶¹Ô´´ Size by Country (2019-2024)
9.4 Latin America Biologics Analytical Services Âé¶¹Ô´´ Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologics Analytical Services Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East & Africa Biologics Analytical Services Âé¶¹Ô´´ Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Biologics Analytical Services Âé¶¹Ô´´ Size by Country (2019-2024)
10.4 Middle East & Africa Biologics Analytical Services Âé¶¹Ô´´ Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Detail
11.1.2 Catalent Business Overview
11.1.3 Catalent Biologics Analytical Services Introduction
11.1.4 Catalent Revenue in Biologics Analytical Services Business (2019-2024)
11.1.5 Catalent Recent Development
11.2 Almac
11.2.1 Almac Company Detail
11.2.2 Almac Business Overview
11.2.3 Almac Biologics Analytical Services Introduction
11.2.4 Almac Revenue in Biologics Analytical Services Business (2019-2024)
11.2.5 Almac Recent Development
11.3 Lonza
11.3.1 Lonza Company Detail
11.3.2 Lonza Business Overview
11.3.3 Lonza Biologics Analytical Services Introduction
11.3.4 Lonza Revenue in Biologics Analytical Services Business (2019-2024)
11.3.5 Lonza Recent Development
11.4 Crystal Pharmatech
11.4.1 Crystal Pharmatech Company Detail
11.4.2 Crystal Pharmatech Business Overview
11.4.3 Crystal Pharmatech Biologics Analytical Services Introduction
11.4.4 Crystal Pharmatech Revenue in Biologics Analytical Services Business (2019-2024)
11.4.5 Crystal Pharmatech Recent Development
11.5 Frontage Labs
11.5.1 Frontage Labs Company Detail
11.5.2 Frontage Labs Business Overview
11.5.3 Frontage Labs Biologics Analytical Services Introduction
11.5.4 Frontage Labs Revenue in Biologics Analytical Services Business (2019-2024)
11.5.5 Frontage Labs Recent Development
11.6 WuXi Biologics
11.6.1 WuXi Biologics Company Detail
11.6.2 WuXi Biologics Business Overview
11.6.3 WuXi Biologics Biologics Analytical Services Introduction
11.6.4 WuXi Biologics Revenue in Biologics Analytical Services Business (2019-2024)
11.6.5 WuXi Biologics Recent Development
11.7 ABS
11.7.1 ABS Company Detail
11.7.2 ABS Business Overview
11.7.3 ABS Biologics Analytical Services Introduction
11.7.4 ABS Revenue in Biologics Analytical Services Business (2019-2024)
11.7.5 ABS Recent Development
11.8 Charles River
11.8.1 Charles River Company Detail
11.8.2 Charles River Business Overview
11.8.3 Charles River Biologics Analytical Services Introduction
11.8.4 Charles River Revenue in Biologics Analytical Services Business (2019-2024)
11.8.5 Charles River Recent Development
11.9 Sartorius
11.9.1 Sartorius Company Detail
11.9.2 Sartorius Business Overview
11.9.3 Sartorius Biologics Analytical Services Introduction
11.9.4 Sartorius Revenue in Biologics Analytical Services Business (2019-2024)
11.9.5 Sartorius Recent Development
11.10 Avid Bioservices
11.10.1 Avid Bioservices Company Detail
11.10.2 Avid Bioservices Business Overview
11.10.3 Avid Bioservices Biologics Analytical Services Introduction
11.10.4 Avid Bioservices Revenue in Biologics Analytical Services Business (2019-2024)
11.10.5 Avid Bioservices Recent Development
11.11 Samsung Biologics
11.11.1 Samsung Biologics Company Detail
11.11.2 Samsung Biologics Business Overview
11.11.3 Samsung Biologics Biologics Analytical Services Introduction
11.11.4 Samsung Biologics Revenue in Biologics Analytical Services Business (2019-2024)
11.11.5 Samsung Biologics Recent Development
11.12 AGC Biologics
11.12.1 AGC Biologics Company Detail
11.12.2 AGC Biologics Business Overview
11.12.3 AGC Biologics Biologics Analytical Services Introduction
11.12.4 AGC Biologics Revenue in Biologics Analytical Services Business (2019-2024)
11.12.5 AGC Biologics Recent Development
11.13 Biodextris
11.13.1 Biodextris Company Detail
11.13.2 Biodextris Business Overview
11.13.3 Biodextris Biologics Analytical Services Introduction
11.13.4 Biodextris Revenue in Biologics Analytical Services Business (2019-2024)
11.13.5 Biodextris Recent Development
11.14 ChemPartner
11.14.1 ChemPartner Company Detail
11.14.2 ChemPartner Business Overview
11.14.3 ChemPartner Biologics Analytical Services Introduction
11.14.4 ChemPartner Revenue in Biologics Analytical Services Business (2019-2024)
11.14.5 ChemPartner Recent Development
11.15 LOTTE BIOLOGICS
11.15.1 LOTTE BIOLOGICS Company Detail
11.15.2 LOTTE BIOLOGICS Business Overview
11.15.3 LOTTE BIOLOGICS Biologics Analytical Services Introduction
11.15.4 LOTTE BIOLOGICS Revenue in Biologics Analytical Services Business (2019-2024)
11.15.5 LOTTE BIOLOGICS Recent Development
11.16 Eurofins Advinus
11.16.1 Eurofins Advinus Company Detail
11.16.2 Eurofins Advinus Business Overview
11.16.3 Eurofins Advinus Biologics Analytical Services Introduction
11.16.4 Eurofins Advinus Revenue in Biologics Analytical Services Business (2019-2024)
11.16.5 Eurofins Advinus Recent Development
11.17 Solvias
11.17.1 Solvias Company Detail
11.17.2 Solvias Business Overview
11.17.3 Solvias Biologics Analytical Services Introduction
11.17.4 Solvias Revenue in Biologics Analytical Services Business (2019-2024)
11.17.5 Solvias Recent Development
11.18 RSSL
11.18.1 RSSL Company Detail
11.18.2 RSSL Business Overview
11.18.3 RSSL Biologics Analytical Services Introduction
11.18.4 RSSL Revenue in Biologics Analytical Services Business (2019-2024)
11.18.5 RSSL Recent Development
11.19 Cytovance Biologics
11.19.1 Cytovance Biologics Company Detail
11.19.2 Cytovance Biologics Business Overview
11.19.3 Cytovance Biologics Biologics Analytical Services Introduction
11.19.4 Cytovance Biologics Revenue in Biologics Analytical Services Business (2019-2024)
11.19.5 Cytovance Biologics Recent Development
11.20 Zencore Biologics
11.20.1 Zencore Biologics Company Detail
11.20.2 Zencore Biologics Business Overview
11.20.3 Zencore Biologics Biologics Analytical Services Introduction
11.20.4 Zencore Biologics Revenue in Biologics Analytical Services Business (2019-2024)
11.20.5 Zencore Biologics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Catalent
Almac
Lonza
Crystal Pharmatech
Frontage Labs
WuXi Biologics
ABS
Charles River
Sartorius
Avid Bioservices
Samsung Biologics
AGC Biologics
Biodextris
ChemPartner
LOTTE BIOLOGICS
Eurofins Advinus
Solvias
RSSL
Cytovance Biologics
Zencore Biologics
Ìý
Ìý
*If Applicable.
